Potential Glioblastoma Therapy with Cationic Cyclodextrin Polymers as Drug Delivery Excipients
Glioblastoma (GB) is the most common and aggressive malignant brain tumor, with a median survival of only 12–15 months despite
Tag: brain cancer
Repurposing neurological drugs for brain cancer therapeutics
Treatment of glioblastoma (GBM) presents significant challenges due to its high degree of heterogeneity and poor prognosis. Recurrence of the